| Ticker: | BIPSX |
| Manager: | Hratch Najarian |
| Manager Since: | 10/11 |
| NAV (05/21/2013): | 144.45 |
| Objective: | Equity - Sector Health |
| Peer: | HL LG |
| Net Assets ($mil): | 3.58 |
| Inception: | 06/19/2000 |
BIPSX : Description
The fund was incepted in June 2000 and is managed by ProFund Advisors. The fund seeks daily investment results that correspond to 150%, before fees and expenses, of the performance of the Dow Jones U.S. Biotechnology Index. The fund primarily invests in biotechnology companies. It concentrates investments in a particular industry or group of industries to approximately the same extent the Index is concentrated. The fund may invest in equity caps, collars and floors, swaps, American Depositary Receipts and options on securities and securities indices. Dividends and capital gains are distributed annually.
BIPSX : Composition - 05/13
| Stocks | 55.83% |
| Foreign Stocks | 0.00% |
| Cash | 0.00% |
| Bonds | 0.00% |
| Foreign Bonds | 0.00% |
| Preferred | 0.00% |
| Convertible | 0.00% |
| Other | 44.17% |
| Foreign Hedged | 0.00% |
BIPSX : Style Analysis - 05/13
| Large Growth | 49.95% |
| Large Value | 0.00% |
| Small Growth | 0.00% |
| Small Value | 0.00% |
| Foreign Stock | 49.95% |
| Emerging Market | 0.00% |
| Precious Metals | 0.00% |
| Intermediate Bond | 0.00% |
| High Yield Bond | 0.00% |
| Foreign Bond | 0.00% |
BIPSX : Risk Analysis
| Beta v. S&P 500 | 1.74 |
| Beta v. EAFE | -0.19 |
| Beta v. Barclays Agg Bond | 2.88 |
| Alpha 3 Yr | 21.32 |
| Alpha 5 Yr | 20.49 |
| R-Sq 3 Yr | 0.54 |
| R-Sq 5 Yr | 0.35 |
| Std Dev 3 Yr | 26.67 |
| Std Dev 5 Yr | 30.18 |
| Sharpe 3 Yr | 1.63 |
| Sharpe 5 Yr | 0.93 |
BIPSX : Fees
| Expense Ratio | 2.72 |
| % Max Load | NA |
| % Min Load | NA |
| % Deferred Load | NA |
| % Redemption | NA |
| % Max 12 B1 Fee | 1.00 |
| % Max Mgt Fee | 0.75 |
BIPSX : Purchase Choices:
| Min Initial Investment | 15000 |
| Min Subsequent Investment | 0 |
BIPSX : Returns Analysis - Annual
| 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | YTD | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAV ($) | 38.46 | 44.32 | 55.84 | 50.42 | 47.51 | 46.50 | 47.50 | 50.02 | 53.74 | 88.23 | 144.45 |
| Total Return (%) | 60.19 | 15.23 | 25.99 | -9.70 | -5.77 | -2.12 | 2.15 | 5.30 | 7.43 | 64.18 | 53.27 |
| Annual Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Relative Performance | |||||||||||
| Rel Performance-S&P500(%) | 314.99 | 43.65 | 211.04 | -255.03 | -112.66 | 348.80 | -242.70 | -97.58 | 53.39 | 481.87 | 405.27 |
| Rel Performance-Obj.Ret.(%) | 296.45 | 64.58 | 170.32 | -134.42 | -146.36 | 215.69 | -197.26 | -27.19 | -3.10 | 449.48 | 336.88 |
| Ret.Quintile vs Obj(1 is best) | 1 | 1 | 1 | 5 | 5 | 1 | 5 | 4 | 3 | 1 | 1 |
| Turnover, Yields, and Gains | |||||||||||
| Fund Assets Net($mil) | 1 | 5 | 7 | 6 | 1 | 5 | 1 | 1 | 1 | 2 | 4 |
| Annual Turnover (%) | 2,288.00 | 562.00 | 510.00 | 396.00 | 373.00 | 519.00 | 762.00 | 297.00 | 37.00 | 6.00 | |
| Annual Dividend Paid ($) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Annual Capital Gains Paid($) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
BIPSX : Returns Analysis - Trailing Total Return
| 1 Month | 3 Month | 6 Month | YTD | 1 Year | 3 Year | 5 Year | 10 Year | 15 Year | 20 Year | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Return (through 05/13) | 11.82% | 38.07% | 63.55% | 53.27% | 92.06% | 38.90% | 23.00% | 16.39% | NA | NA |
| Ret. Percentile vs. Obj. (1 is best) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | NA | NA |
BIPSX : Stock Portfolio Snapshot - 05/13
| Average Price/Earnings | 36.43 |
| Average Price/Book | 5.82 |
| Average EPS Growth | 12.92 |
| Average Market Value | 36,473.00 |
BIPSX : Stock Sector Breakout - 05/13
BIPSX : Top Holdings - 05/13
| Name | Weight | Shares |
|---|---|---|
| AMGEN INC | 10.04 | 97,055 |
| GILEAD SCIENCES INC | 9.15 | 191,478 |
| ABBOTT LABORATORIES | 8.89 | 200,032 |
| CELGENE CORP | 6.43 | 53,627 |
| VERTEX PHARMACEUTICALS INC | 1.48 | 27,307 |
| ALEXION PHARMACEUTICALS INC | 2.81 | 24,675 |
| REGENERON PHARMACEUTICALS | 2.01 | 9,541 |
| LIFE TECHNOLOGIES CORP | 1.70 | 21,714 |
| BIOGEN IDEC INC | 5.66 | 29,939 |